HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice

BACKGROUND: Hepatitis B virus (HBV) persistently infected about 250 million people worldwide, and a curative treatment remains an unmet medical need. Among many approaches to treat chronic hepatitis B (CHB), therapeutic vaccines have been developed for two decades, but none have yielded promising re...

Descripción completa

Detalles Bibliográficos
Autores principales: Horng, Jau-Hau, Lin, Wei-Hsiang, Wu, Chang-Ru, Lin, You-Yu, Wu, Li-Ling, Chen, Ding-Shinn, Chen, Pei-Jer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257178/
https://www.ncbi.nlm.nih.gov/pubmed/32466788
http://dx.doi.org/10.1186/s12929-020-00662-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7257178/
https://www.ncbi.nlm.nih.gov/pubmed/32466788
http://dx.doi.org/10.1186/s12929-020-00662-x

Ejemplares similares